Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innate immune mechanisms of mRNA vaccines.
Verbeke R, Hogan MJ, Loré K, Pardi N. Verbeke R, et al. Immunity. 2022 Nov 8;55(11):1993-2005. doi: 10.1016/j.immuni.2022.10.014. Immunity. 2022. PMID: 36351374 Free PMC article. Review.
The dawn of mRNA vaccines: The COVID-19 case.
Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Verbeke R, et al. J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798667 Free PMC article. Review.
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. Schoenmaker L, et al. Among authors: verbeke r. Int J Pharm. 2021 May 15;601:120586. doi: 10.1016/j.ijpharm.2021.120586. Epub 2021 Apr 9. Int J Pharm. 2021. PMID: 33839230 Free PMC article. Review.
Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer.
Meulewaeter S, Zhang Y, Wadhwa A, Fox K, Lentacker I, Harder KW, Cullis PR, De Smedt SC, Cheng MHY, Verbeke R. Meulewaeter S, et al. Among authors: verbeke r. J Mol Biol. 2024 Jan 15;436(2):168385. doi: 10.1016/j.jmb.2023.168385. Epub 2023 Dec 6. J Mol Biol. 2024. PMID: 38065276 Review.
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
Meulewaeter S, Aernout I, Deprez J, Engelen Y, De Velder M, Franceschini L, Breckpot K, Van Calenbergh S, Asselman C, Boucher K, Impens F, De Smedt SC, Verbeke R, Lentacker I. Meulewaeter S, et al. Among authors: verbeke r. J Control Release. 2024 May 4;370:379-391. doi: 10.1016/j.jconrel.2024.04.052. Online ahead of print. J Control Release. 2024. PMID: 38697317 Free article.
130 results